Document Page: First | Prev | Next | All | Image | This Release | Search

File: 110196_aacpr_01.txt
Page: 01
Total Pages: 1

SUBJECT:  BW/CW POLICY

DESCRIPTION:  POLICY ABOUT REPLACEMENT OF EXPIRED ANTIDOTES

PAAEZYUW RHIUFAA0000 0000000-EEEE--0000000.
ZNY EEEEE
FM USCENTAF//9A//
TO RHIEFBA/31 TAC HOSP DEPLOYED//SG//
RUFLGGA/836 TAC HOSP DEPLOYED//SG//
BT
UNCLAS E F T O
SUBJ:  BW/CW POLICY
1.  MANY INDIVIDUALS THROUGHOUT THE THEATER HAVE BEEN INADVERTANT-
LY ISSUED EXPIRED BW/CW ANTIDOTES.  THIS HAS RAISED MANY QUES-
TIONS CONCERNING THE POLICY ABOUT THE USE OF EXPIRED ANTIDOTES.
2.  USCENTAF/SG POLICY IS TO REPLACE ALL EXPIRED ANTIDOTES WITH
NEW STOCKS.  THIS WILL REQUIRE YOU TO REQUISITION REPLACEMENTS
FROM USAMMCE PIRMASENS AS KNOWN EXPIRED ASSETS ARE IDENTIFIED.
INDIVIDUALS IN POSSESSION OF EXPIRED ANTIDOTES SHOULD HOLD UNTO
THEM AS BEING USEABLE UNTIL REPLACED.
3.  WIDEST DISSEMINATION MUST BE MADE TO MAKE ALL INDIVIDUALS
SUPPORTED BY A HOST ATH.  THE HOST ATH SHOULD AGGRESIVELY DETER-
MINE REPLACEMENTS REQUIREMENTS FROM THESE OFFSITE SMES.
4.  MEDICAL LOGISTICS WILL RETAIN ALL EXPIRED BW/CW ANTIDOTES AND
PLACE IN SEGREGATED STORAGE TO PREVENT ACCIDENTAL REISSUE.  RE-
PORTING REQUIREMENTS FOR TESTING IAW AFM 67-1 VOL V WILL BE
ADDRESSED AT A LATER DATE.

			[(b)(2)]
BT



NNNN







[(b)(6)]

Document Page: First | Prev | Next | All | Image | This Release | Search